Quest Diagnostics reports Q3 2026 earnings and raises full-year guidance
Third-quarter revenue grew 10% to $3.1 billion with adjusted EPS up 15%. The company lifted full-year revenue and profit expectations driven by strong organic growth.
See the latest news and media coverage for Quest. We track all announcements, press releases, and industry mentions in real time, all in one place.
Medical diagnostic testing and laboratory services provider
questdiagnostics.comLast updated
In short: Quest reported a Quanum cybersecurity breach, beat Q3 revenue expectations, and raised full-year guidance.
Third-quarter revenue grew 10% to $3.1 billion with adjusted EPS up 15%. The company lifted full-year revenue and profit expectations driven by strong organic growth.
The company projects 4-5% revenue CAGR and 7-9% EPS CAGR beyond 2025, driven by Project Nova and advanced diagnostics investments.
National data highlights prevalent Babesia antibodies alongside Lyme disease, informing clinical awareness of complex exposures.
The company adds Roche pTau217 to its AD-Detect portfolio and introduces a multi-biomarker lab-developed test with low indeterminate rates.
Medical laboratory operator Quest Diagnostics said it learned of a cyber breach of one of its systems this week, likely compromising some records for patients.
Detailed price information for Quest Diagnostics Inc (DGX-N) from The Globe and Mail including charting and trades.
AMCA has not given Quest or Optum360 more information about the incident, including which information of which individuals could have been affected. Quest said it...
Quest Diagnostics (DGX) is down 12.8% today. Here is some analysis on what might have caused this price movement.Analysis: The most likely driver appears to...
Track Quest and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Quest and other trending companies.